Small Molecules
18 March 2013
Trimel Reports Positive CompleoTRT(TM) Phase III Results for Secondary Efficacy and Safety Endpoints18 March 2013
Virobay and LEO Pharma Initiate a Phase 1 Trial of VBY-891, a Compound Intended for Oral Treatment of Psoriasis16 March 2013
Novartis compound LDK378 receives FDA Breakthrough Therapy designation for ALK+ non-small cell lung cancer13 March 2013
N30 Pharmaceuticals Announces First Patient Treated in Clinical Trial of N6022 in Cystic Fibrosis12 March 2013
Merck Provides Update on IMPROVE-IT Trial12 March 2013
Lithera Initiates Phase 2b Clinical Trial of LIPO-202 Targeting Aesthetic Reduction of Subcutaneous Abdominal Fat12 March 2013
Radius Health Completes Enrollment for Phase 3 Study of Bone-Building Osteoporosis DrugNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe![Newsletter La Merie Biologics](https://pipelinereview.com/wp-content/uploads/2024/02/newsletter-1.png)
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe![Newsletter new product alert](https://pipelinereview.com/wp-content/uploads/2024/02/report-alert.png)
Featured reports